This article is more than 5 years old. Information may no longer be current.

Iridex's G-Probe Illuminate receives CE mark

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The G-Probe Illuminate glaucoma device from Iridex has received a CE mark and is now available in Europe, according to a company press release.

The G-Probe Illuminate, with combined transillumination and laser fiber for targeted transscleral cyclophotocoagulation, is the third probe in the Cyclo G6 glaucoma laser system.

It can be used in the operating room or as an outpatient office-based procedure for treating glaucoma, according to the release. It was launched in the United States in early 2017 when it received FDA clearance.

“The prevalence of glaucoma is only increasing around the world, and Iridex is committed to improving and expanding the therapeutic options for both patients and surgeons,” Iridex CEO William M. Moore said in the release.